For more information or confidential assistance
Call 800-306-3180

Judge Identifies Pradaxa Bellwether Lawsuits

diane 35 blood clot risk
The litigation process for product liability multidistrict litigation (MDL) No. 2385 is moving steadily forward. U.S. District Judge Robert R. Herndon issued a Case Management Order on January 23, 2014, which identified the first four Pradaxa bleeding injury lawsuits to be heard in court. The... Read More

Pradaxa Bleeding Problems and Adverse Event Reports

Pradaxa FDA warning
For the second year in a row, the controversial anticoagulant Pradaxa leads all other drugs in adverse event reports submitted to the Federal Drug Administration (FDA).  According to an analysis by the Institute for Safe Medication Practices (ISMP), in 2012 the FDA Adverse Event Reporting System... Read More

New Study Examines Pradaxa Internal Bleeding Risks

diane 35 blood clot risk
Manufactured by Boehringer Ingelheim, Pradaxa is promoted as a more convenient alternative to its predecessor warfarin for stroke prevention, as the medication entails less rigorous medical monitoring. Despite this convenience, the anticoagulant, which has no known antidote to quell bleeding events, has been linked to... Read More

Pradaxa Gastrointestinal Bleeding Lawsuit Filed

Pradaxa FDA warning
Plaintiff Joseph Dasaro has filed a Pradaxa gastrointestinal bleeding lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim International GmbH, for personal injuries and wrongful death suffered after the death of his mother, Rose Dasaro, which he alleges was caused by her use of the... Read More